Matrix Asset Advisors’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
BBHC
Matrix Asset Advisors's NVS Position: Q1 2018 in Review
Matrix Asset Advisors sold out of Novartis (NVS) in Q1 2018, closing a stake of 3,046 shares — an estimated $229K sold.
Matrix Asset Advisors first reported a position in NVS in Q2 2017 and held it in 3 quarters. The position peaked at $286K in Q3 2017. 1,012 funds tracked by Wall St. Rank hold NVS as of Q1 2018.
- Matrix Asset Advisors reported no remaining Novartis position as of Q1 2018 after selling out during the quarter.
- Matrix Asset Advisors sold 3,046 Novartis shares in Q1 2018, an estimated $229K.
- Matrix Asset Advisors first reported a position in Novartis in Q2 2017 and held it in 3 quarters.
- Matrix Asset Advisors's Novartis position peaked at $286K in Q3 2017.
- 1,012 funds tracked by Wall St. Rank held Novartis as of Q1 2018.
Based on Matrix Asset Advisors's 13F filing for Q1 2018, filed 15 May 2018.